Allergan Investors Urge Class Cert. In Insider Trading Row
Allergan investors accusing Valeant Pharmaceuticals of unlawfully tipping off hedge fund Pershing Square about an unsolicited $55 billion takeover bid of Allergan asked a California federal judge Tuesday to grant the...To view the full article, register now.
Already a subscriber? Click here to view full article